Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
New immunization research reported from Cangene Corporation
April 2nd, 2008
Current study results from the report, 'Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents,' have been published. According to a study from Mississauga, Canada, "Burkholderia pseudomallei is a biothreat agent and an important natural pathogen, causing melioidosis in humans and animals. A type III secretion system (TTSS-3) has been shown to be critical for virulence." "Because TTSS components from other pathogens have been used successfully as diagnostic agents and as experimental vaccines, it was investigated whether this was the case for BipB, BipC and BipD, components of B. pseudomallei's TTSS-3. The sequences of BipB,...
Source: Vaccine Weekly (2008-04-02)
|
